Concetta Quintarelli

5.1k total citations
67 papers, 2.4k citations indexed

About

Concetta Quintarelli is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, Concetta Quintarelli has authored 67 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 34 papers in Immunology and 13 papers in Hematology. Recurrent topics in Concetta Quintarelli's work include CAR-T cell therapy research (36 papers), Immune Cell Function and Interaction (20 papers) and Virus-based gene therapy research (11 papers). Concetta Quintarelli is often cited by papers focused on CAR-T cell therapy research (36 papers), Immune Cell Function and Interaction (20 papers) and Virus-based gene therapy research (11 papers). Concetta Quintarelli collaborates with scholars based in Italy, United States and Germany. Concetta Quintarelli's co-authors include Franco Locatelli, Barbara Savoldo, Gianpietro Dotti, Helen E. Heslop, Cliona M. Rooney, Biagio De Angelis, Malcolm K. Brenner, Valentina Hoyos, Juan F. Vera and Fabrizio Pane and has published in prestigious journals such as Blood, Cancer Research and Oncogene.

In The Last Decade

Concetta Quintarelli

64 papers receiving 2.4k citations

Peers

Countries citing papers authored by Concetta Quintarelli

Since Specialization

Citations

This map shows the geographic impact of Concetta Quintarelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Concetta Quintarelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Concetta Quintarelli more than expected).

Fields of papers citing papers by Concetta Quintarelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Concetta Quintarelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Concetta Quintarelli. The network helps show where Concetta Quintarelli may publish in the future.

Co-authorship network of co-authors of Concetta Quintarelli

This figure shows the co-authorship network connecting the top 25 collaborators of Concetta Quintarelli. A scholar is included among the top collaborators of Concetta Quintarelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Concetta Quintarelli. Concetta Quintarelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	GMP-manufactured CRISPR/Cas9 technology as an advantageous tool to support cancer immunotherapy	Journal of Experimental & Clinical Cancer Research	Stefano Iacovelli, Concetta Quintarelli et al.	7
2	CD7.Pebl-CART for Patients with Relapsed/Refractory (r/r) T-Cell Acute Lymphoblastic Leukemia (T-ALL)	Blood	Francesca Del Bufalo, Pietro Merli et al.	1
3	Allogeneic chimeric antigen receptor T cells for children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia	Haematologica	Franco Locatelli, Francesca Del Bufalo et al.	6
4	The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumors	Frontiers in Immunology	Giada Del Baldo, Francesca Del Bufalo et al.	18
5	Insight into immune profile associated with vitiligo onset and anti-tumoral response in melanoma patients receiving anti-PD-1 immunotherapy	Frontiers in Immunology	Maria Luigia Carbone, Alessia Capone et al.	15
6	Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML	Blood Advances	Giulia Pianigiani, Federica Mezzasoma et al.	22
7	Nanoparticles for Diagnosis and Target Therapy in Pediatric Brain Cancers	Diagnostics	Gabriele Maiorano, Angela Mastronuzzi et al.	25
8	PI3K/Akt Pathway: The Indestructible Role of a Vintage Target as a Support to the Most Recent Immunotherapeutic Approaches	Cancers	Emmanuel de Billy, Biagio De Angelis et al.	26
9	Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We?	Frontiers in Immunology	Concetta Quintarelli, Antonio Camera et al.	5
10	Stimuli-responsive nanoparticle-assisted immunotherapy: a new weapon against solid tumours	Journal of Materials Chemistry B	Biagio De Angelis, Nicoletta Depalo et al.	40
11	NK Cell-Based Immunotherapy for Hematological Malignancies	Journal of Clinical Medicine	Simona Sivori, Raffaella Meazza et al.	50
12	Human CAR-NK cells: A new non-viral method allowing high efficient transfection and target cell killing		Tiziano Ingegnere, Francesca Romana Mariotti et al.	1
13	Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation	Haematologica	Pietro Merli, Ignazio Caruana et al.	49
14	Adoptive Immunotherapy Using PRAME-Specific T Cells in Medulloblastoma	Cancer Research	Domenico Orlando, Evelina Miele et al.	56
15	Choice of costimulatory domains and of cytokines determines CAR T-cell activity in neuroblastoma	OncoImmunology	Concetta Quintarelli, Domenico Orlando et al.	106
16	Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model	OncoImmunology	Paola Bocca, Emma Di Carlo et al.	95
17	Identification of Annexin A1 interacting proteins in chronic myeloid leukemia KCL22 cells	PROTEOMICS	Nicola Esposito, Concetta Quintarelli et al.	8
18	Selective strong synergism of Ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemia	Leukemia Research	Concetta Quintarelli, Biagio De Angelis et al.	22
19	Gene Therapy to Improve Function of T Cells for Adoptive Immunotherapy	Methods in molecular biology	Concetta Quintarelli, Barbara Savoldo et al.	10
20	Genetic Manipulation of Tumor-specific Cytotoxic T Lymphocytes to Restore Responsiveness to IL-7	Molecular Therapy	Juan F. Vera, Valentina Hoyos et al.	82

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact